Home
About
Technology
Pipeline
Investors
News
Contact

Home
About
Technology
Pipeline
Investors
News
Contact

Nouscom will present at Biocapital Europe

Home » Nouscom will present at Biocapital Europe

Nouscom will present at Biocapital Europe

Nouscom will present at Biocapital Europe2018-02-062018-05-14http://www.nouscom.com/wp-content/uploads/2018/03/artboard-3.pngNouscomhttp://www.nouscom.com/wp-content/uploads/2018/03/artboard-3.png200px200px

Find out the full program here: http://www.biocapitaleurope.com

Recent Posts

Nouscom Strengthens its Management Team
Nouscom – First Patient Dosed in a Phase 1 Trial with NOUS-209, an ‘off-the-shelf’ Neoantigen Cancer Vaccine, in MSI-High Solid Tumors
Nouscom will join & present at the SITC 2019
Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium

Contact

NOUSCOM
info@nouscom.com
nouscom.com

Our Privacy

Privacy Policy & Cookie Low

Nouscom is a private oncology company developing next generation immunotherapies, founded in 2015 by an experienced management team that has worked together for many years in previous successful enterprises. Nouscom’s proprietary technology platform harnesses the full power of the immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.

© Copyright 2018 | Made with by

error: Content is protected !!!

NousCom presents at Agenda Sachs ForumMeetings

Nouscom will present at the World Vaccine Congress Europe 2018Meetings

Utilizziamo i cookie per essere sicuri che tu possa avere la migliore esperienza sul nostro sito. Se continui ad utilizzare questo sito noi assumiamo che tu ne sia felice.Ok